These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 15534857

  • 21. Drug use investigation (DUI) and prescription-event monitoring in Japan (J-PEM).
    Tanaka K, Morita Y, Kawabe E, Kubota K.
    Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):653-8. PubMed ID: 11980256
    [Abstract] [Full Text] [Related]

  • 22. Databases for pediatric medicine research in Europe--assessment and critical appraisal.
    Neubert A, Sturkenboom MC, Murray ML, Verhamme KM, Nicolosi A, Giaquinto C, Ceci A, Wong IC, TEDDY Network of Excellence.
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1155-67. PubMed ID: 18979461
    [Abstract] [Full Text] [Related]

  • 23. A computerized system for signal detection in spontaneous reporting system of Shanghai China.
    Ye X, Fu Z, Wang H, Du W, Wang R, Sun Y, Gao Q, He J.
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):154-8. PubMed ID: 19115240
    [Abstract] [Full Text] [Related]

  • 24. Pharmacovigilance systems and databases in Korea, Japan, and Taiwan.
    Kimura T, Matsushita Y, Yang YH, Choi NK, Park BJ.
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1237-45. PubMed ID: 21936017
    [Abstract] [Full Text] [Related]

  • 25. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy.
    Salvo F, Polimeni G, Moretti U, Conforti A, Leone R, Leoni O, Motola D, Dusi G, Caputi AP.
    J Antimicrob Chemother; 2007 Jul; 60(1):121-6. PubMed ID: 17449881
    [Abstract] [Full Text] [Related]

  • 26. Building a structured monitoring and evaluating system of postmarketing drug use in Shanghai.
    Du W, Levine M, Wang L, Zhang Y, Yi C, Wang H, Wang X, Xie H, Xu J, Jin H, Wang T, Huang G, Wu Y.
    Can J Clin Pharmacol; 2007 Jul; 14(1):e40-4. PubMed ID: 17237524
    [Abstract] [Full Text] [Related]

  • 27. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS, Lee YW, Choi YH, Park B, Jee YK, Choi SK, Kim EG, Park JW, Hong CS.
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [Abstract] [Full Text] [Related]

  • 28. Population-based drug-related anaphylaxis in children and adolescents captured by South Carolina Emergency Room Hospital Discharge Database (SCERHDD) (2000-2002).
    West SL, D'Aloisio AA, Ringel-Kulka T, Waller AE, Clayton Bordley W.
    Pharmacoepidemiol Drug Saf; 2007 Dec; 16(12):1255-67. PubMed ID: 17918773
    [Abstract] [Full Text] [Related]

  • 29. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S, Desboeuf K, Fernet P, Montastruc JL, Lapeyre-Mestre M.
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [Abstract] [Full Text] [Related]

  • 30. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use.
    Fraunfelder FW, Richards AB.
    Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555
    [Abstract] [Full Text] [Related]

  • 31. Development of pharmacovigilance system in Ukraine: first results.
    Stefanov O, Sharayeva M, Jajtchenja V.
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):197-9. PubMed ID: 15072120
    [Abstract] [Full Text] [Related]

  • 32. Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a univeristy hospital in Riyadh.
    Al-Malaq HM, Al-Aqeel SA, Al-Sultan MS.
    Saudi Med J; 2008 Aug; 29(8):1145-50. PubMed ID: 18690308
    [Abstract] [Full Text] [Related]

  • 33. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
    von Euler M, Eliasson E, Ohlén G, Bergman U.
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
    [Abstract] [Full Text] [Related]

  • 34. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ, Spielmann H.
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [Abstract] [Full Text] [Related]

  • 35. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK, Swartz L.
    Arch Intern Med; 2005 Jun 27; 165(12):1363-9. PubMed ID: 15983284
    [Abstract] [Full Text] [Related]

  • 36. Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
    Corrao G, Botteri E, Bagnardi V, Zambon A, Carobbio A, Falcone C, Leoni O.
    Pharmacoepidemiol Drug Saf; 2005 Jan 27; 14(1):31-40. PubMed ID: 15390219
    [Abstract] [Full Text] [Related]

  • 37. Diplopia and fluoroquinolones.
    Fraunfelder FW, Fraunfelder FT.
    Ophthalmology; 2009 Sep 27; 116(9):1814-7. PubMed ID: 19643481
    [Abstract] [Full Text] [Related]

  • 38. Making the most of spontaneous adverse drug reaction reporting.
    Waller PC.
    Basic Clin Pharmacol Toxicol; 2006 Mar 27; 98(3):320-3. PubMed ID: 16611209
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Continuous challenges in Japanese forensic toxicology practice: strategy to address specific goals].
    Kageura M.
    Nihon Hoigaku Zasshi; 2002 Sep 27; 56(2-3):219-28. PubMed ID: 12415829
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.